BDSX · Healthcare · $238M
$29.18+0.14%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 39 Medical - Diagnostics & Research peers
Quarterly Revenue Growth
“진단검사 매출이 전년 동기 대비 42%, 검사 건수가 38% 늘며 핵심 사업이 강해졌어요.”
In the company's words · 2026 2분기 earnings call